Other endocrine disorders
Notes: Constitutional delay of growth, puberty, or maturation ; Acid-labile subunit gene (IGFALS) defect ; Growth hormone gene 1 (GH1) defect with growth hormone neutralizing antibodies ; Growth hormone insensitivity syndrome (GHIS) ; Insulin-like growth factor 1 gene (IGF1) defect ; Laron type short stature ; Severe primary insulin-like growth factor-1 deficiency (SPIGFD) ; Signal transducer and activator of transcription 5B gene (STAT5b) defect ; Genetic syndrome with resistance to insulin-like growth factor-1 ; Insulin-like growth factor-1 receptor (IGF-1R) defect ; Post-insulin-like growth factor-1 receptor signaling defect ; Short stature due to ACAN gene variant ; Short stature due to aggrecan deficiency ; Short stature due to NPR-2 gene variant ; Constitutional gigantism ; Androgen insensitivity NOS ; Complete androgen insensitivity ; de Quervain syndrome ; Goldberg-Maxwell syndrome ; Partial androgen insensitivity ; Reifenstein syndrome ; Pineal gland dysfunction ; Progeria ; Endocrine disturbance NOS ; Hormone disturbance NOS ; pseudohypoparathyroidism (E20.1) ; ectopic ACTH syndrome (E24.3) ; achondroplastic short stature (Q77.4) ; hypochondroplastic short stature (Q77.4) ; nutritional short stature (E45) ; pituitary short stature (E23.0) ; progeria (E34.8) ; renal short stature (N25.0) ; Russell-Silver syndrome (Q87.19) ; short-limbed stature with immunodeficiency (D82.2) ; short stature (child) (R62.52) ; short stature in specific dysmorphic syndromes – code to syndrome – see Alphabetical Index ; short stature NOS (R62.52) ; pseudohypoparathyroidism (E20.1) ; May be used as an additional code to identify functional activity associated with a carcinoid tumor.